15 results · 21ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

LITTLE ANGELS SWADDLING BLANKET

FDA 510(k)
FDA Class 2 ·General Hospital

Alpha 1 Acid Glycoprotein RID plate package

FDA UDI
KENT LABORATORIES INC·B1761234·Radial immunodiffusion plate package for Human ...

IDEAL IQ SOFTWARE OPTION

FDA 510(k)
FDA Class 2 ·Radiology

STEELEX STERNUM SET

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

VERSAFITCUP DM DOUBLE MOBILITY HC LINER Ø 48/28

FDA Adverse Event
Injury ·MEDACTA INTERNATIONAL SA·Product code MEH·August 17, 2018

2032227-2019-123411

FDA Adverse Event
Malfunction ·Product code OYC·November 27, 2019

DEXCOM G7 CONTINUOUS GLUCOSE MONITORING SYSTEM

FDA Adverse Event
Malfunction ·DEXCOM, INC.·Product code QBJ·May 20, 2025

ROD, UNKNOWN SIZE

FDA Adverse Event
Injury ·ZIMMER BIOMET SPINE INC.·Product code MNH·May 14, 2019

ACCUSURE

FDA Adverse Event
Malfunction ·FEEL TECH·Product code FMF·December 17, 2008

LCP 4.5/5 BROAD CURV 14HO L265 SST

FDA Adverse Event
Injury ·SYNTHES GMBH·Product code KTT·May 21, 2013

PARADIGM REAL-TIME REVEL INSULIN INFUSION PUMP

FDA Adverse Event
Malfunction ·MEDTRONIC MINIMED·Product code OYC·September 26, 2014

PROWLER SELECT

FDA Adverse Event
Malfunction ·MEDOS INTERNATIONAL SARL·Product code KRA·February 19, 2025

CERENOVUS ENTERPRISE

FDA Adverse Event
Malfunction ·MEDOS INTERNATIONAL SARL·Product code NJE·February 19, 2025

KING LAD Standard ClearSeal SINGLE USE, King Systems ETO Sterilie10 devices/case Size 3 / Child ClearSeal King LAD¿ Patient Size: 30-50kg Product Usage: Laryngeal airway

FDA Enforcement
Class II ·Terminated·King Systems Corp.·November 28, 2012

CADD-Solis VIP ambulatory Infusion Pumps, Model 2110. Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024